日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma

Zanidatamab联合Tislelizumab和化疗一线治疗HER2阳性胃/胃食管交界处腺癌的Ib/II期研究

Lee, Keun-Wook; Bai, Li-Yuan; Jung, Minkyu; Ying, Jieer; Im, Young-Hyuck; Oh, Do-Youn; Cho, Jae Yong; Oh, Sang Cheul; Chao, Yee; Kim, Jin Won; Chen, Ye; Li, Vincent; Chen, Shengnan; Kang, Yoon-Koo

Impact of Junior Physicians' Resignation on Palliative Sedation Practices: A Retrospective Single-Center Study in South Korea

初级医师离职对姑息镇静实践的影响:韩国一项回顾性单中心研究

Hong, Moonki; Lee, Si Won; Jung, Minkyu

Development of 3D Reversible Smart Energy-Saving Devices for Adaptive Energy Management

用于自适应能源管理的3D可逆智能节能装置的开发

Jin, Ho Jun; Seo, Junyong; Chung, Ha Uk; Jung, Minkyu; Kim, Simon; Lee, Su Eon; Park, Jun Hyun; Choe, Jun Seok; Kim, Sun-Kyung; Lee, Bong Jae; Kim, Jin-Tae; Kim, Bong Hoon

Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum

基于常规临床、实验室和病理参数的真实世界疗效和生物标志物分析:一线抗PD-1联合氟尿嘧啶和铂类药物治疗转移性或不可切除食管癌的疗效及生物标志物分析

Jeong, Jiyun; Seo, Seyoung; Kim, Sung-Bae; Song, Joon Seon; Kim, Hye Ryun; Cho, Byoung Chul; Jung, Minkyu; Kim, Chang Gon; Hong, Moonki; Hong, Min Hee; Park, Sook Ryun

Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial

nProfiler 1 检测对 III 期胃癌辅助 S-1 双药化疗疗效的预测价值:一项随机 III 期试验的事后分析

Lee, Dong Ki; Lee, Choong-Kun; Kim, Hyo Song; Sym, Sun Jin; Zang, Dae Young; Kim, Ki Hyang; Lim, Joo Han; Kim, Hae Su; Lee, Kyung Hee; Gee, Heon Yung; Rha, Sun Young; Kim, Hyunki; Jung, Minkyu

Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma

探索黑色素瘤中的分子遗传改变和RAF融合:一项针对RAS/RAF突变型黑色素瘤患者的贝尔伐非尼扩大用药计划

Kim, Kyoo Hyun; Cho, Sungmin; Jeong, Yeyeong; Baek, Eun Sil; Lee, Chung; Ryu, Hyang-Joo; Noh, Young Su; Hong, Yoon-Hee; Chung, Kee Yang; Roh, Mi Ryung; Oh, Byung Ho; Kim, Chang Gon; Jung, Minkyu; Shin, Sang Joon

First-in-Human Phase 1 Study of a B Cell- and Monocyte-Based Immunotherapeutic Vaccine against HER2-Positive Advanced Gastric Cancer

针对HER2阳性晚期胃癌的基于B细胞和单核细胞的免疫治疗疫苗的首次人体I期研究

Jung, Minkyu; Lee, Jii Bum; Kim, Hyo Song; Kwon, Woo Sun; Kim, Hyun Ok; Kim, Sinyoung; Park, Myunghwan; Kim, Wuhyun; Choi, Ki-Young; Oh, Taegwon; Kang, Chang-Yuil; Chung, Hyun Cheol; Rha, Sun Young

Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13)

Varlitinib 和紫杉醇治疗 EGFR/HER2 共表达的晚期胃癌:一项多中心 Ib/II 期研究 (K-MASTER-13)

Koo, Dong-Hoe; Jung, Minkyu; Kim, Yeul Hong; Jeung, Hei-Cheul; Zang, Dae Young; Bae, Woo Kyun; Kim, Hyunki; Kim, Hyo Song; Lee, Choong-Kun; Kwon, Woo Sun; Chung, Hyun Cheol; Rha, Sun Young

Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)

晚期胃癌患者三线免疫检查点抑制剂与伊立替康化疗的真实世界疗效:一项韩国多中心研究(KCSG ST22-06)

Lim, Sung Hee; Lee, Keun-Wook; Kim, Jae-Joon; Im, Hyeon-Su; Kim, In-Ho; Han, Hye Sook; Koo, Dong-Hoe; Cho, Jang Ho; Maeng, Chi Hoon; Lee, Min-Young; Lee, Hyo Jin; Kim, Jwa Hoon; Park, Sang Gon; Jung, Joo Young; Shin, Seong-Hoon; Kim, Ki Hyang; Kim, Hyeyeong; Oh, So Yeon; Kang, Minsu; Jung, Minkyu; Rha, Sun Young

Prediction of Bone Marrow Metastases Using Computed Tomography (CT) Radiomics in Patients with Gastric Cancer: Uncovering Invisible Metastases

利用计算机断层扫描(CT)放射组学预测胃癌患者的骨髓转移:揭示隐匿性转移

Park, Jiwoo; Jung, Minkyu; Kim, Sang Kyum; Lee, Young Han